Metrics Offers New Proprietary Technology to Improve Taste, Stability & Deliver SR Characteristics
Metrics Inc. now offers proprietary technology to mask the taste of tablets. The company’s innovative Cleantaste technology enables polymer coating of individual drug crystals to produce fine, non-gritty particles sized 25 to 125 micrometers. This technology can improve the taste and mouth-feel of drugs and can be used to support stability or deliver sustained-release characteristics.
“Cleantaste technology is suitable for orally dispersible tablets and encapsulated products,†said Dr. Brad Gold, Vice President of Pharmaceutical Development. “If patients don’t take their medications because they taste bad – or they’re difficult to swallow – then that obviously can have serious detrimental effects on treatment plans and health outcomes. We want to help patients comply with prescription regimens by improving the palatability of medications and making them easier to swallow. Cleantaste technology allows us to do that.â€
Metrics Inc. is a full-service global pharmaceutical development and manufacturing organization serving clients worldwide. The addition of Cleantaste technology to Metrics’ portfolio of formulation and manufacturing capabilities is the result of its recent acquisition by Mayne Pharma Group Limited. Together, Metrics and Mayne offer an impressive proprietary portfolio of advanced drug delivery technologies for controlled release, bioavailability enhancement, and taste-masking. For more information, visit www.metricsinc.com.
Total Page Views: 814
